Atlas Trials

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

Clinical trial NCT04920032 · RECRUITING

Trial details

NCT number
NCT04920032
Sponsor
University of California, Irvine
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Colon AdenocarcinomaColorectal Cancer
Start date
2021-08-26
Primary completion
2027-01-21
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.